BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 35880515)

  • 1. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
    Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-month comparison of clinical outcomes between continuous-flow left ventricular assist devices.
    Itzhaki Ben Zadok O; Ben-Avraham B; Shaul A; Hammer Y; Rubachevski V; Aravot D; Kornowski R; Ben-Gal T
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1054-1061. PubMed ID: 31566245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
    Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34491776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34315231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support.
    Numan L; Ramjankhan FZ; Oberski DL; Oerlemans MIFJ; Aarts E; Gianoli M; Van Der Heijden JJ; De Jonge N; Van Der Kaaij NP; Meuwese CL; Mokhles MM; Oppelaar AM; De Waal EEC; Asselbergs FW; Van Laake LW
    ESC Heart Fail; 2021 Apr; 8(2):1596-1603. PubMed ID: 33635573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Patients With HeartMate3 Versus HeartWare Ventricular Assist Device Implanted as Destination Therapy.
    Wasilewski G; Kędziora A; Wiśniowska-Śmiałek S; Tomsia P; Kaleta M; Wierzbicki K
    Transplant Proc; 2022 May; 54(4):1049-1053. PubMed ID: 35431097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions.
    Soltani S; Kaufmann F; Vierecke J; Kretzschmar A; Hennig E; Stein J; Hetzer R; Krabatsch T; Potapov EV
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):984-9. PubMed ID: 25209626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®.
    Schramm R; Zittermann A; Morshuis M; Schoenbrodt M; von Roessing E; von Dossow V; Koster A; Fox H; Hakim-Meibodi K; Gummert JF
    ESC Heart Fail; 2020 Jun; 7(3):908-914. PubMed ID: 32190985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: the EUROMACS analysis.
    Potapov EV; Nersesian G; Lewin D; Özbaran M; de By TMMH; Stein J; Pya Y; Gummert J; Ramjankhan F; Zembala MO; Damman K; Carrel T; Meyns B; Zimpfer D; Netuka I
    Eur J Cardiothorac Surg; 2021 Sep; 60(3):579-587. PubMed ID: 33871594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Assist Device Malfunctions: It Is More Than Just the Pump.
    Kormos RL; McCall M; Althouse A; Lagazzi L; Schaub R; Kormos MA; Zaldonis JA; Sciortino C; Lockard K; Kuntz N; Dunn E; Teuteberg JJ
    Circulation; 2017 Oct; 136(18):1714-1725. PubMed ID: 28674109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device.
    Shin K; Cho WC; Shin N; Kim HR; Kim MS; Chung CH; Jung SH
    J Chest Surg; 2024 Mar; 57(2):184-194. PubMed ID: 38360679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widening care gap in VAD therapy.
    Conway J; Amdani S; Morales DLS; Lorts A; Rosenthal DN; Jacobs JP; Rossano J; Koehl D; Kirklin JK; Auerbach SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1710-1724. PubMed ID: 37591455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
    Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA
    J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.